Dopamine enhances model-free credit assignment through boosting of retrospective model-based inference

  1. Lorenz Deserno  Is a corresponding author
  2. Rani Moran  Is a corresponding author
  3. Jochen Michely
  4. Ying Lee
  5. Peter Dayan
  6. Raymond J Dolan
  1. Max Planck Institute for Human Cognitive and Brain Sciences, Germany
  2. University College London, United Kingdom
  3. Charité - Universitätsmedizin Berlin, Germany
  4. TU Dresden, Germany
  5. Max Planck Institute for Biological Cybernetics, Germany

Abstract

Dopamine is implicated in representing model-free (MF) reward prediction errors a as well as influencing model-based (MB) credit assignment and choice. Putative cooperative interactions between MB and MF systems include a guidance of MF credit assignment by MB inference. Here, we used a double-blind, placebo-controlled, within-subjects design to test an hypothesis that enhancing dopamine levels boosts the guidance of MF credit assignment by MB inference. In line with this, we found that levodopa enhanced guidance of MF credit assignment by MB inference, without impacting MF and MB influences directly. This drug effect correlated negatively with a dopamine-dependent change in purely MB credit assignment, possibly reflecting a trade-off between these two MB components of behavioural control. Our findings of a dopamine boost in MB inference guidance of MF learning highlights a novel DA influence on MB-MF cooperative interactions.

Data availability

Necessary source data files are openly available at: https://osf.io/4dfkv/.

Article and author information

Author details

  1. Lorenz Deserno

    Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
    For correspondence
    deserno_l@ukw.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7392-5280
  2. Rani Moran

    Max Planck UCL Centre for Computational Psychiatry and Ageing Research, University College London, London, United Kingdom
    For correspondence
    rani.moran@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7641-2402
  3. Jochen Michely

    Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3072-2330
  4. Ying Lee

    Psychiatry and Psychology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9491-4919
  5. Peter Dayan

    Max Planck Ring 8, Max Planck Institute for Biological Cybernetics, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3476-1839
  6. Raymond J Dolan

    The Wellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9356-761X

Funding

Wellcome Trust (098362/Z/12/Z)

  • Raymond J Dolan

Max-Planck-Gesellschaft (Open-access funding)

  • Lorenz Deserno
  • Rani Moran
  • Peter Dayan
  • Raymond J Dolan

Deutsche Forschungsgemeinschaft (402170461)

  • Lorenz Deserno
  • Raymond J Dolan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study was approved by the University College London Research Ethics Committee (Project ID 11285/001). Subjects gave written informed consent before the experiment.

Copyright

© 2021, Deserno et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,428
    views
  • 255
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lorenz Deserno
  2. Rani Moran
  3. Jochen Michely
  4. Ying Lee
  5. Peter Dayan
  6. Raymond J Dolan
(2021)
Dopamine enhances model-free credit assignment through boosting of retrospective model-based inference
eLife 10:e67778.
https://doi.org/10.7554/eLife.67778

Share this article

https://doi.org/10.7554/eLife.67778

Further reading

    1. Cell Biology
    2. Neuroscience
    Luting Yang, Chunqing Hu ... Yaping Yan
    Research Article

    Reactive astrocytes play critical roles in the occurrence of various neurological diseases such as multiple sclerosis. Activation of astrocytes is often accompanied by a glycolysis-dominant metabolic switch. However, the role and molecular mechanism of metabolic reprogramming in activation of astrocytes have not been clarified. Here, we found that PKM2, a rate-limiting enzyme of glycolysis, displayed nuclear translocation in astrocytes of EAE (experimental autoimmune encephalomyelitis) mice, an animal model of multiple sclerosis. Prevention of PKM2 nuclear import by DASA-58 significantly reduced the activation of mice primary astrocytes, which was observed by decreased proliferation, glycolysis and secretion of inflammatory cytokines. Most importantly, we identified the ubiquitination-mediated regulation of PKM2 nuclear import by ubiquitin ligase TRIM21. TRIM21 interacted with PKM2, promoted its nuclear translocation and stimulated its nuclear activity to phosphorylate STAT3, NF-κB and interact with c-myc. Further single-cell RNA sequencing and immunofluorescence staining demonstrated that TRIM21 expression was upregulated in astrocytes of EAE. TRIM21 overexpressing in mice primary astrocytes enhanced PKM2-dependent glycolysis and proliferation, which could be reversed by DASA-58. Moreover, intracerebroventricular injection of a lentiviral vector to knockdown TRIM21 in astrocytes or intraperitoneal injection of TEPP-46, which inhibit the nuclear translocation of PKM2, effectively decreased disease severity, CNS inflammation and demyelination in EAE. Collectively, our study provides novel insights into the pathological function of nuclear glycolytic enzyme PKM2 and ubiquitination-mediated regulatory mechanism that are involved in astrocyte activation. Targeting this axis may be a potential therapeutic strategy for the treatment of astrocyte-involved neurological disease.

    1. Neuroscience
    Felix Michaud, Ruggiero Francavilla ... Lisa Topolnik
    Research Article

    Alzheimer’s disease (AD) leads to progressive memory decline, and alterations in hippocampal function are among the earliest pathological features observed in human and animal studies. GABAergic interneurons (INs) within the hippocampus coordinate network activity, among which type 3 interneuron-specific (I-S3) cells expressing vasoactive intestinal polypeptide and calretinin play a crucial role. These cells provide primarily disinhibition to principal excitatory cells (PCs) in the hippocampal CA1 region, regulating incoming inputs and memory formation. However, it remains unclear whether AD pathology induces changes in the activity of I-S3 cells, impacting the hippocampal network motifs. Here, using young adult 3xTg-AD mice, we found that while the density and morphology of I-S3 cells remain unaffected, there were significant changes in their firing output. Specifically, I-S3 cells displayed elongated action potentials and decreased firing rates, which was associated with a reduced inhibition of CA1 INs and their higher recruitment during spatial decision-making and object exploration tasks. Furthermore, the activation of CA1 PCs was also impacted, signifying early disruptions in CA1 network functionality. These findings suggest that altered firing patterns of I-S3 cells might initiate early-stage dysfunction in hippocampal CA1 circuits, potentially influencing the progression of AD pathology.